Navigation Links
Connecticut Innovations Closes Investment with Paygilant
Date:10/3/2019

Connecticut Innovations (CI), Connecticut’s strategic venture capital arm and the leading source of financing and ongoing support for Connecticut’s innovative, growing companies, today announced that it has closed on a $750,000 investment in Paygilant, an Israel-based fraud protection company for mobile payments and winner of the 2018 VentureClash competition.

The outlay is part of a larger investment round being raised that will help Paygilant establish its Connecticut-based U.S. headquarters and will be applied toward sales and marketing hires, product development, implementation support and general working capital for operations.

“We are excited to welcome Paygilant, an innovative cybersecurity company with tremendous prospects, to Connecticut,” said Peter Longo, senior managing director of investments at Connecticut Innovations. “In less than a year since going to market, the company has completed multiple successful installations and won a number of prestigious industry awards. We are looking forward to continuing to support Paygilant and its management team as the company grows here in Connecticut.”

Founded in Israel, Paygilant’s unique frictionless authentication and mobile fraud prevention integrates and correlates multi-intelligence data sets to determine fraudulent behavior. Without impacting and imposing on the user, Paygilant runs in the background to seamlessly stop fraud before any damage is done. Using machine learning, Paygilant provides ongoing and continuous data analysis ensuring that transactions are approved only for legitimate users.

“Through our successful involvement with the VentureClash program, it became clear that Connecticut was the right place for us to establish our U.S. presence,” said Ziv Cohen, CEO of Paygilant. “We are honored to have the support of Connecticut Innovations and look forward to growing our team and our business within the state.”

About Connecticut Innovations
Connecticut Innovations (CI) is Connecticut’s strategic venture capital arm and the leading source of financing and ongoing support for Connecticut’s innovative, growing companies. CI provides venture capital and strategic support for early-stage technology companies, financial support for innovation and collaboration, and connections to its well-established network of partners and professionals. For more information, please visit http://www.ctinnovations.com.

About Paygilant
Paygilant makes digital payments safer, faster and easier.

Paygilant’s unique frictionless authentication and mobile fraud prevention solution integrates and correlates multi-intelligence data sets to determine fraudulent behaviour. Without impacting and imposing on the user, Paygilant runs in the background to seamlessly stop fraud before any damage is done. Using machine learning algorithms, Paygilant provides ongoing and continuous data analysis ensuring that payments and transactions are approved only for legitimate users.

What makes Paygilant unique is that it does not rely on Behavioral Biometrics as the sole criteria for authentication, rather incorporates additional fraud indicators including Device Indicators and Transaction Analysis. Paygilant combines Device Indicators, Behavioral Biometrics and Transaction Analysis to decisively identify fraudsters from legitimate customers.

Media Contact:
Lauren Carmody
lauren.carmody@ctinnovations.com
860.258.7829

Read the full story at https://www.prweb.com/releases/connecticut_innovations_closes_investment_with_paygilant/prweb16608936.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology news :

1. Preferred Gum Surgery Alternative Treats Gum Disease in Waterbury, CT at Advanced Periodontics and Dental Implant Center of Connecticut
2. Connecticut River watershed study will assess impacts of extreme rain events
3. Cardea Bio and Nanosens Innovations Look to Combine Companies
4. Stem Cell Innovations Launches ICO Pre-Sale
5. DERMALOG Presents its Latest Biometric Innovations at the Hannover CeBIT Exhibition, 16 - 20 March 2015
6. NSF and NIH collaborate to accelerate advance of biomedical innovations into the marketplace
7. NIH and NSF collaborate to accelerate biomedical research innovations into the marketplace
8. NREL staff recognized for top innovations
9. NREL expert honored for energy systems innovations
10. 83 global health innovations receive Grand Challenges Canada funding
11. Innovations save lives of mothers and children
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2019)... ... October 10, 2019 , ... ... ultrasound, invites attendees of the American Society of Anesthesiologists 2019 Annual Meeting to ... on October 19-21 in Orlando, Florida, and will provide more than 14,000 healthcare ...
(Date:10/8/2019)... (PRWEB) , ... October 07, 2019 , ... The future ... to the genetic level, resulting in people living longer, healthier lives. But it will ... on earth. , Leroy E. Hood, MD, PhD, Chief Strategy Officer and Co-Founder of ...
(Date:10/3/2019)... ... October 02, 2019 , ... Personalized Stem Cells, ... patient in an FDA approved clinical trial for stem cell treatment of knee ... formation of the company as a subsidiary of VetStem Biopharma. , PSC CEO, Michael ...
Breaking Biology News(10 mins):
(Date:10/10/2019)... , ... October 09, 2019 , ... ... Abernethy, MD, PhD, Principal Deputy Commissioner, FDA, as a newly-confirmed keynote speaker for ... 2019 in Las Vegas, Nevada USA. , Dr. Abernethy, a hematologist/oncologist and palliative ...
(Date:10/10/2019)... ... October 10, 2019 , ... R3 Stem Cell announces it has ... October 18-19th, 2019 in Las Vegas with spots still open. , The speaker, Dr. ... several Ivy League universities including Cornell, Harvard and Dartmouth. He currently serves as the ...
(Date:10/8/2019)... ... October 08, 2019 , ... ... Madhumita Suresh and Leslie Maurer presented company executives with a set of recommendations ... (MBS) graduates will offer insights from their TMP to a wider audience of ...
(Date:10/8/2019)... ... October 08, 2019 , ... Today, Massachusetts stem cell biotechnology company ... technology. Like the company’s precursor patent, approved in the U.S. in 2017, the ... stem cells. Asymmetrex now markets the technology in the U.S. as the AlphaSTEM ...
Breaking Biology Technology: